Our enrichment analysis demonstrated that ARL11 expression is involved in several immunosuppressing processes in BC, including T cell differentiation and PD-L1 expression and the PD-1 checkpoint pathway in cancer. This evidence concerns the gene ARL11 and breast cancer.